Tomorrow’s public meeting at the FDA on the US pre-market notification process may lay the foundations for a change in the scope of the 510(k). Interest in the session, in Gaithersburg, Maryland, has been high: registration closed on February 12 and the FDA has been warning it ...
Please Login to read the full article.
